Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma (CTCL) and represents nearly 50% of all primary cutaneous lymphomas. 1 It occurs mostly in elderly adults (age ≥55 years) but can also be seen in children and young adults. The male-to-female ratio is about 2:1. There is usually a prolonged clinical course with evolution of patches and plaques to tumor stage in some patients. 1-3 Less than one-third of patients develop advanced disease involving lymph nodes, blood, and visceral organs. 4, 5 Morphologically, the neoplastic lymphoid infiltrate is epidermotropic and composed predominantly of small-to intermediate-sized atypical lymphocytes with enlarged hyperchromatic, cerebriform nuclei and clear cytoplasm (haloed cells). These atypical lymphocytes often colonize the basal layer of epidermis singly or in a linear fashion, forming a "string of pearls." Pautrier microabscesses, which consist of small aggregates of atypical lymphocytes often in association with Langerhans cells, can be helpful in the diagnosis but are seen in less than 25% of cases. 6, 7 MF is a clonal disorder of memory T-helper cells, in which progressive immunodeficiency of the hosts occurs, and consequently, patients may develop severe infections in the advanced stages. Immunodeficiency results not only from expansion of the dysfunctional and malignant T cells but also from the immunosuppressive role that the neoplastic T cells play in conjunction with regulatory T cells and other complex factors and pathways. [8] [9] [10] [11] [12] [13] Ancillary studies may be useful in aiding the diagnosis of MF. The neoplastic T cells in MF are usually CD4+ mature T cells, expressing T-cell receptor (TCR) b and variable T-cellassociated antigens such as CD2, CD3, CD5, and CD7. 14, 15 Loss of 1 or more of these pan-T-cell markers (most often CD7, followed by CD5) is common. In evaluating immunohistochemical stains, it is helpful to consider the epidermal and dermal components independently because the dermal component may contain numerous inflammatory or reactive lymphocytes. As many as 20% of cases of early MF display a CD8+ phenotype, 16 which occurs more frequently in pediatric cases and is more commonly associated with hypopigmented and hyperpigmented lesions. 6, [17] [18] [19] [20] [21] The clinical behavior of CD8+ MF is similar to that of the CD4 type. 6, [16] [17] [18] [19] [20] [21] Molecular studies may reveal clonal T-cell gene rearrangements by polymerase chain reaction (PCR) analysis. Gene rearrangement studies are not required for diagnosis and may be misleading because clonal T cells are frequently found in inflammatory skin conditions. To increase the specificity and diagnostic value of the T-cell clonality evaluation by molecular analysis, some investigators suggest using 2 sets of primers for detecting both the TCR b and g genes, 22, 23 as well as detecting identical clones from 2 different skin sites. 24 In skin biopsy samples in which the percentage of suspected neoplastic T cells is low, it is recommended to assess the PCR target in duplicate to demonstrate reproducibility of the signals. 23 The objective of this report is to summarize practical issues and common diagnostic challenges that were raised in session 1 during the panel review as well as case presentations at the 2011 Workshop of the Society for Hematopathology and European Association for Haematopathology. The discussions concentrate on (1) pitfalls in diagnosing early MF; (2) assessment of nodal involvement; (3) definition, prognosis, and differential of transformed MF; (4) relationship of MF with primary cutaneous CD30+ T-cell lymphoproliferative disorders (LPDs); (5) clinically significant MF variants; and (6) Sézary syndrome.
Pitfalls in Diagnosing Early MF
Accurate diagnosis of early MF is essential for staging, prognostic stratification, and determining therapeutic options. In practice, however, the diagnosis of patch and early plaque stage MF can be very challenging because of its overlapping clinicopathologic findings with various reactive dermatoses as well as conflicting clinical presentations and pathologic features. In 2005, the International Society for Cutaneous Lymphoma (ISCL) developed an algorithm for diagnosing early MF based on a combined approach of using both clinical and pathologic criteria from diverse methodologies ❚Table 1❚. 25 The algorithm was subsequently validated on a large scale in practice, 26 leading to the conclusion that utilization of the combined clinical and pathologic criteria should be considered for evaluating early MF. For cases that are clinically concerning for early MF but do not display clear-cut diagnostic features, rebiopsy is recommended. 26 Case 165 was a 70-year-old man who had a characteristic clinical presentation of early MF with a 6-year history of erythematous patches of variable size and shape in the sun-protected areas on his thighs, buttocks, and lower abdomen. were considered, especially primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma (discussed by Quintanilla-Martinez et al 29 in this issue of the journal), which has a much more aggressive clinical behavior and presents as eruptive papulonodules with ulceration or necrosis. 30 Early MF, as the name implies, is evaluated and diagnosed without the benefit of having a classic clinical course of evolution from patches to plaques and, in some cases, to tumor lesions. It may lack the characteristic features of epidermotropism, including formation of Pautrier microabscess, which occurs in about 20% of the cases. Therefore, it may be indistinguishable from reactive dermatoses and is often misdiagnosed initially as eczema or psoriasis, as seen in cases 165 and 65. In this situation, clinical information may be invaluable in avoiding misdiagnosis. The characteristics of reactive dermatoses mimicking MF are discussed by Sarantopoulos et al 31 in this issue of the journal. To diagnose early MF with confidence, a comprehensive assessment of clinical history is absolutely essential, and pathologic criteria alone may be insufficient. In several cases of MF submitted to this session, the panel was unable to make a definitive diagnosis because of a lack of clinical information, such as a description of the skin lesions and drug history. Clinical photographs are invaluable to the overall assessment as the skin patches or thin plaques in early MF display heterogeneity in size and shape, 25 whereas unilesional MF is rare. 32 Because morphologic findings of early MF or treated lesions often show only minimal to mild epidermotropism without Pautrier microabscess, obtaining repeat or multiple biopsy specimens from various lesions may be helpful. T-cell aberrancies such as loss of CD7 in a significant component (eg, >50% at the very least) of the epidermotropic lymphocytes and/or loss of CD2, CD3, or CD5 may also be contributory. 25 T-cell gene rearrangement studies when performed may not be helpful in the diagnosis of early MF because negative results do not necessarily exclude the diagnosis of MF, as in case 165, whereas clonal T-cell gene rearrangements can be detected in benign dermatoses, as in case 271.
Assessment of Nodal Involvement
Assessment of lymph node involvement is an important component for staging MF and has significant prognostic implications. Patients with nodal or other extracutaneous involvement have a reported 10-year disease-specific survival of less than 20%. In 2007, the ISCL and European Organization for Research and Treatment of Cancer (EORTC) proposed updates of the staging and classification of MF and Sézary syndrome (SS). 33 These updates were incorporated in the histopathologic staging of lymph nodes in MF and SS by the current World Health Organization (WHO) classification, 2, 3 in which clinically abnormal lymph nodes (>1.5 ❚Image 1E❚, and ❚Image 1F❚ demonstrated CD4+ T cells displaying significant loss of CD7 within the epidermis. Molecular studies were negative for both clonal TCR b and g gene rearrangements. The panel diagnosis was early MF despite the negative clonal T-cell gene rearrangements. In contrast, case 271 showed positive clonal TCR g gene rearrangement in a 29-year-old woman, who presented with a chest and abdominal skin rash with blanching and recent use of minocycline. The biopsy specimen showed a superficial dermal lymphoid infiltration with prominent spongiosis and a vase-shaped "pseudo-Pautrier microabscess," 27 composed predominantly of Langerhans cells with only rare T cells ❚Image 2A❚, ❚Image 2B❚, ❚Image 2C❚, and ❚Image 2D❚. Despite the clonal T-cell gene rearrangements, the panel diagnosis was superficial spongiotic dermatitis. Similar to case 271, spongiosis was also a noticeable feature of case 82, which the submitter and the panel did diagnose as MF. However, unlike case 271, the spongiosis was only focal ❚Image 2E❚, and the remaining clinicopathologic findings were typical of MF. Although "epidermotropism without spongiosis" was considered a histopathologic criterion in the ISCL algorithm for diagnosing early MF, 25 spongiosis can be seen in about 30% of MF cases. 28 When present, it is mostly mild or focal and should be concurrent with disproportionate epidermotropism.
Case 65 represented a case of pediatric MF in which the early diagnosis can be especially challenging because of the patient's young age, frequent unusual CD8+ immunophenotype, and more variable clinical presentation. The patient was a 6-year-old boy with an 18-month history of recurrent erythematous papulonodules and white scaly patches. He was initially diagnosed with spongiotic and psoriasiform dermatitis, treated as pityriasis lichenoides with azithromycin and then narrow-band UV-B phototherapy plus methotrexate, but he had continued disease. His skin showed hypopigmented patches and pink-red papulonodules on the back ❚Image 3A❚. The biopsy specimen of a hypopigmented patch showed a mild superficial dermal infiltrate of small atypical lymphocytes with sparse epidermotropism. In the biopsy specimen of a papulonodule ❚Image 3B❚, the atypical lymphoid infiltrate was more visible with more prominent epidermotropism, including rare, small Pautrier microabscesses. Immunohistochemical studies highlighted CD8+ T cells ❚Image 3C❚, and molecular studies demonstrated identical clonal TCR g gene rearrangements in both specimens. Similar to case 65, case 313 ❚Image 3D❚, ❚Image 3E❚, ❚Image 3F❚, ❚Image 3G❚, ❚Image 3H❚, and ❚Image 3I❚ was CD8+ hypopigmented MF with hypopigmented patches and erythematous plaques, but the patient was a 38-year-old African American man. The skin biopsy specimen revealed striking epidermotropism, and immunohistochemical studies showed prominent loss of CD5 and near-complete loss of CD7 within the epidermotropic atypical lymphocytes. Because of the marked epidermotropism, several differential diagnoses cm) in MF/SS are divided into 3 categories (N1, N2, and N3), depending on the degree of involvement. Recognition of early nodal involvement, such as in categories N1 and N2, can be extremely difficult by morphologic examination alone, because the lymph nodes display only dermatopathic changes without architectural effacement and cerebriform lymphocytes are sparse in single forms or very small clusters of fewer than 6 cells. The ISCL/EORTC recommended excisional biopsy as the preferred method in evaluating nodal involvement, in addition to having a portion of the node processed for ancillary studies, including immunophenotyping by immunohistochemistry and flow cytometry, and/or molecular genetic or cytogenetic analysis. Flow cytometric analysis may be of special value because it can detect T-cell aberrancies with relatively high sensitivity and specificity and, therefore, may confer a more precise histologic stage. Case 264 demonstrated a comprehensive approach to identify nodal infiltration by MF ❚Image 4❚ and illustrated the utility of ancillary studies. The patient was a 57-year-old woman with pruritic rash for 5 years. She had several biopsies over a period of 9 months that demonstrated progression of MF. The most recent biopsy specimen of right brachial skin revealed a dense lichenoid dermal lymphoid infiltrate composed of admixed small-to intermediate-sized cerebriform lymphocytes and aggregates to sheets of large atypical lymphocytes with smooth nuclei, dispersed chromatin, and prominent nucleoli. A lymph node biopsy sample taken 3 months later showed partial effacement of the nodal architecture by large aggregates to sheets of small-to intermediate-sized cerebriform lymphocytes, in a background of dermatopathic changes. Flow cytometric studies indicated an abnormal CD4+ T-cell subset (about 30% of the T cells) with aberrant dim CD3 and complete loss of CD7. Molecular analysis detected identical clonal T-cell gene rearrangements in the skin and lymph node biopsy specimens. The panel diagnosis of the right brachial skin was large-cell transformation (LCT) of mycosis Although the diagnosis of transformed MF is made based on comprehensive analysis of both the clinical and pathologic criteria, considerations of the key differentials are important for staging, prognosis, and therapy. Because of the shared morphologic features with an abundance of large blast cells and common expression of CD30, it is critical to distinguish LCT of MF from primary cutaneous anaplastic large-cell lymphoma (cALCL), which is discussed in the next section, as well as from cutaneous manifestation of systemic ALCL. Expression of CD15 is uncommon in transformed MF, 42 but when it occurs, it is frequently accompanied by expression of CD30. ALCL may show similar immunophenotypic features to LCT because a subset of either systemic or cutaneous ALCL may express CD15. 42 Peripheral T-cell lymphoma not otherwise specified coexpressing CD30 and CD15 should also be considered because it may also involve cutaneous sites. 43, 44 Last, because MF can coexist with classical Hodgkin lymphoma (CHL), the distinction of concurrent MF and CHL from transformed MF with CHL-like features is necessary.
Relationship With Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disorders
According to the 2008 WHO classification, 2,3 patients with cutaneous ALCL should not have clinical evidence or a history of MF. When they do, the diagnosis should be only 2 (cases 123 and 186). In addition, immunophenotypic switch of the neoplastic T cells was detected in cases 137 (CD4+ and CD8+ MF to CD4+ LCT) and 279 (CD4+ MF to CD8+ LCT). Furthermore, cross-lineage aberrancy was observed in case 63 with expression of CD20 in a subset of the neoplastic T cells.
Patients who present with LCT at more advanced stages have worse prognosis, and extracutaneous transformation is frequently associated with poor survival. 35, 36, 40 However, a recent study reported that some cases of LCT may follow a more indolent course. 40 Using multivariate analysis, this study showed that CD30 negativity, folliculotropic MF, extent of skin lesions, and extracutaneous transformation were associated with reduced disease-specific survival, with the latter two being associated with reduced overall survival.
Case 63 presented a 78-year-old man with a longstanding history of skin patches and plaques that were first diagnosed as psoriasis. The patient developed skin tumors ❚Image 5A❚, and after 6 months a biopsy was performed ❚Image 5B❚, ❚Image 5C❚, ❚Image 5D❚, and ❚Image 5E❚, revealing extensive and dense lymphoid infiltration of the dermis with epidermotropism. The lymphoid infiltrate was composed mainly of admixed small to large cerebriform lymphocytes, as well as large transformed cells (or blasts) with slightly irregular nuclei, dispersed chromatin, and prominent nucleoli. Immunophenotypic analysis revealed double-negative (CD4-and CD8-) T cells expressing CD3 with loss of both CD5 and CD7, as well as aberrant expression of CD20. The conclusion of the panel was that the number of large transformed T cells was less than 25%, and hence a diagnosis of tumor stage without transformation was rendered. Case 196 presented tumor stage of MF, as well as LCT with sheets of large transformed cells. In cases similar to 63 and 196, the morphologic distinction between nontransformed vs transformed tumor stage MF can be made. However, distinguishing tumor stage MF with or without LCT may not be clinically relevant because studies suggest no difference in survival in patients with tumor stage MF regardless of transformation status. 34, 40, 41 Case 186 was a classic case of MF that progressed to advanced stage with transformation and extracutaneous involvement. It described a patient with stage Ib MF at age 41 years. Over the next 15 years, the disease recurred several times and continued to progress with ulcerated tumors in 2008, despite multiple local and systemic treatments. Clinical photograph and skin biopsy specimen several years prior to 2008 showed findings consistent with patch/plaque stage MF ❚Image 6A❚. In 2008, the skin biopsy specimen of an arm tumor ❚Image 6B❚, ❚Image 6C❚, ❚Image 6D❚, and ❚Image 6E❚ revealed dense dermal infiltration by predominantly large transformed cells and scattered large cerebriform lymphocytes, with frequent mitoses. Immunohistochemical studies lymphocytes were negative for CD8, CD56, CD30, and ALK-1. The patient continued to develop patches, plaques, and ulcerating nodules and tumors that were associated with the plaques ❚Image 7E❚. However, most of those nodules and tumors underwent spontaneous resolution. The biopsy specimen taken from 1 persistent nodule on the scalp ❚Image 7F❚, ❚Image 7G❚, ❚Image 7H❚, ❚Image 7I❚, ❚Image 7J❚, and ❚Image 7K❚ revealed dermal atypical lymphoid infiltrates with aggregates of large atypical lymphocytes with blastlike morphology, admixed with small lymphocytes and eosinophils. The large atypical lymphocytes were positive for CD30 as well as T-cell-associated markers CD2, CD3 (patchy and weak), CD4, and CD5 (patchy and weak), plus perforin, but negative for CD7, CD8, and ALK-1. Based on the clinical information, the persistent nodule on the scalp and the nodules and tumors that underwent spontaneous resolution were more in keeping with primary cutaneous CD30+ LPD (cALCL and LyP) than transformed MF. The panel diagnosis was MF associated with primary cutaneous CD30+ LPD. Similarly, in case 140, the patient presented with concurrent folliculotropic MF and LyP. In addition to coexistence with MF, primary cutaneous CD30+ LPD, especially LyP, is a key consideration in the differential diagnosis of MF due to their overlapping clinicopathologic features. Clinically, LyP has a characteristic presentation of recurrent self-healing papulonodules. Although reappearance and sometimes even spontaneous resolution may occasionally occur in MF, it typically does not present as a chronic, recurrent, and self-healing eruption. Histologically, type B LyP (MF-like) can display findings identical considered transformation of MF to tumor stage, which may be CD30+ or CD30-. 42, 45 Nevertheless, MF may coexist with primary cutaneous CD30+ LPDs (discussed in detail by Quintanilla-Martinez et al 29 ) , including lymphomatoid papulosis (LyP) and cALCL. [45] [46] [47] A clonal relationship between lesions of MF and primary cutaneous CD30+ LPD in the same patient may be demonstrable in some cases by molecular studies. 48 It has been suggested that MF with LyP may be associated with improved survival and decreased risk for disease progression. 49 It is critical to distinguish concurrent MF and primary cutaneous CD30+ LPD from transformed MF because their prognoses and therapeutic implications are significantly different. Such distinction relies primarily on clinical presentations as well as pathologic features. 6p25.3 IRF4/DUSP22 rearrangements by fluorescent in situ hybridization analysis may be helpful because they were observed in about 26% of cALCL (see Quintanilla-Martinez et al 29 ) and only rarely in LyP or transformed MF. 50, 51 Case 72 was a 36-year-old male patient who presented with patches and plaques on the trunk ❚Image 7A❚ and proximal limbs for several years. He was treated initially with intermittent UV-B, psoralen-UV-A, and oral retinoids with some response. A biopsy specimen of the left flank plaque ❚Image 7B❚, ❚Image 7C❚, and ❚Image 7D❚ revealed an epidermotropic atypical lymphoid infiltrate of the dermis with Pautrier microabscesses. Immunohistochemical studies demonstrated a T-cell phenotype, positive for CD2 and CD3, with partial loss of CD5 and significant loss of CD7. Staining for CD4 was focal and weak. The atypical Immunohistochemical studies demonstrated a CD8+ T-cell phenotype expressing CD2 and CD3 with partial loss of CD5 and marked loss of CD7. The epidermotropic lymphocytes were frequently positive for CD30. Staining for cytotoxic molecules was negative. Although the case displayed histopathologic features resembling PR-type MF, the panel rendered the diagnosis of type D LyP based on the overall clinicopathologic features, including clinical presentation of recurrent and partially self-healing papulonodules and striking epidermotropism, plus the CD8+ phenotype and frequent expression of CD30.
to MF, with an epidermotropic infiltrate of small-to intermediate-sized cerebriform lymphocytes. Type D LyP, a recently described entity, shows prominent epidermotropism resembling a variant of MF, pagetoid reticulosis (PR), with a cytotoxic immunophenotype positive for CD8 and CD30. 52 Case 116 cells may be abundant, displaying emperipolesis of small lymphocytes (lymphophagocytosis), and/or contain phagocytized elastic fibers (elastophagocytosis). It can be associated with Hodgkin lymphoma or MF, and it can be confused with other granulomatous processes. Case 306 was a 59-year-old female patient who presented with GSS and a history of preexisting MF. At age 22 years, the patient developed patches and plaques consistent with MF, was treated with total skin electron beam therapy with complete remission, but relapsed 8 years later at age 30 years. At age 40 years, the patient presented with slowly progressive hanging lax skin folds in preexistent MF lesions on the breasts, abdomen, and axillary skin folds, shown in the inset of ❚Image 9G❚. A biopsy specimen of the hanging skin folds (Image 9G), ❚Image 9H❚, and ❚Image 9I❚ revealed dermal granulomatous infiltration with small atypical lymphocytes and abundant giant cells containing numerous nuclei, many of which formed a wreath-like arrangement. There was epidermotropism with small cerebriform lymphocytes, consistent with MF. Lymphophagocytosis was easily seen, which was also a prominent feature of case 239 ❚Image 9J❚. Like GSS, formation of granulomatous aggregates is the main histologic feature of granulomatous MF as well, which only differs clinically from GSS by the development of hanging skin folds in GSS.
Sézary Syndrome
SS, categorized as a separate entity from MF by the WHO/EORTC classification system, is an aggressive disease with a poor prognosis. 1, 4, 59 SS is defined by a classic triad of erythroderma, generalized lymphadenopathy, and clonally related neoplastic T cells with cerebriform nuclei (Sézary cells) in skin, lymph nodes, and peripheral blood. 58 The absolute Sézary cell count is at least 1,000 cells/mL in peripheral blood with a CD4 to CD8 ratio of greater than 10 and/or T-cell aberrancies by immunophenotyping. 59, 60 Case 74 was illustrative of SS. This 84-year-old male patient presented with a 1-year history of progressive nonpruritic erythema. Prior skin biopsy specimen was nondiagnostic, and treatment included topical plus oral steroids. Laboratory studies showed a WBC count of 17,000/mL with 60% lymphocytes. The patient had revealed generalized erythroderma ❚Image 10A❚. A skin biopsy specimen ❚Image 10B❚, ❚Image 10C❚, ❚Image 10D❚, ❚Image 10E❚, ❚Image 10F❚, and ❚Image 10G❚, however, showed only a mild lichenoid atypical lymphoid infiltrate of the dermis with minimal epidermotropism. Immunohistochemical studies highlighted CD4+ T cells displaying loss of CD5 and significant loss of CD7. The panel performed immunohistochemical studies for programmed death 1 (PD-1), which stained many of the atypical lymphocytes. PD-1 is a marker of follicular
MF Variants
Eighteen cases were submitted as various subtypes of MF (MF variants), accounting for approximately 29% of the cases in this session. Close to 15 early MF variants have been reported as of 2010. 52 However, the panel is in agreement with the WHO/EORTC classification 1,2 that the clinically significant variants are limited to folliculotropic MF, PR, and granulomatous slack skin (GSS). These 3 MF variants may be diagnostically challenging owing to their distinctive clinical and pathologic features.
Folliculotropic MF is important to recognize because it may imply a worse prognosis, with 5-year survival rates of approximately 60% to 70%, and may require more intensive treatment. 49, 53, 54 Histologic diagnosis can be difficult because it often lacks the typical epidermotropism seen in MF. Instead, the atypical lymphocytes infiltrate the hair follicles, and abundant inflammatory cells are often present in the background, raising the differential of folliculitis. Some patients may have comedone-like distended hair follicles containing keratinaceous debris. Follicular mucinosis may or may not be present in folliculotropic MF, 53 and it can be seen in other entities, including benign conditions. 55 Case 154, which had typical features of folliculotropic MF, was a 38-year-old male patient who had a history of a pruritic rash for 9 months. Clinical photograph showed erythematous macules, plaques, and papules ❚Image 9A❚. A biopsy specimen revealed hair follicles infiltrated by atypical lymphocytes, admixed with abundant plasma cells and eosinophils ❚Image 9B❚ and ❚Image 9C❚. Epidermotropism was not prominent. The lymphoid cells were predominantly CD4+ T cells by immunohistochemical studies, and molecular analysis revealed clonal TCR b gene rearrangements. Similarly, case 119 exhibited folliculotropic MF, in which follicular mucinosis ❚Image 9D❚ was striking and LCT was also noted.
In contrast to folliculotropic MF, PR and GSS, both of which are rare variants of MF, have an indolent clinical course with excellent prognosis. [56] [57] [58] Cases 257 and 106 presented clinicopathologic features consistent with PR, and case 257 was reported previously. 53 The typical presentation of PR (Woringer-Kolopp type) is a solitary plaque on the distal extremities. Multiple, disseminated lesions are seen in the Ketron-Goodman type. There is characteristic epidermal hyperplasia with striking epidermotropism of atypical lymphocytes ❚Image 9E❚. A CD8+ immunophenotype is common in PR, and expression of CD30 ❚Image 9F❚ is seen in a proportion of cases. The key differentials are MF palmaris et plantaris and primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. GSS 1,58 presents as slowly evolving hanging folds of lax skin in the major skin folds, with dermal granulomatous infiltration by clusters of histiocytes and giant cells surrounded by small lymphocytes that are typically clonal. Epidermotropism may be minimal. Giant gene rearrangements in both the skin and bone marrow biopsy specimens.
Although erythroderma is one of the characteristic presentations of SS, it can also be seen in MF. When that occurs, the term erythrodermic MF is used, and it may be categorized as secondary SS if the other criteria of SS are fulfilled. 33, 60 Case 118 presented a case of erythrodermic MF at tumor stage. Because no information was available regarding the peripheral blood lymphocyte count, assessment of secondary SS could not be made. The patient was a 43-year-old man helper T cells, and recent studies identified PD-1 expression in subgroups of CTCLs. 61, 62 The expression of PD-1 was much more frequent in SS than in MF (with >50% neoplastic T cells positive in 89% of SS vs 13% of MF). 63 A bone marrow biopsy specimen revealed an interstitial lymphocytosis, and flow cytometric studies ❚Image 10H❚ detected a discrete population of abnormal T cells (>90% of the total T cells) with several aberrancies, including dim CD2, dim CD3, bright CD4, and complete loss of CD7. Molecular studies demonstrated identical clonal TCR g Recognition of SS can be challenging, and skin biopsy specimens alone may not be informative. Skin biopsy specimens of SS may not show changes that are typical of MF, and patients may go through several "nondiagnostic" biopsies, as in case 74. Ancillary studies may be helpful in aiding the diagnosis of SS. Multiparametric flow cytometry is useful in detecting and enumerating the neoplastic lymphocytes of SS in the blood. It can reveal pan-T-cell aberrancies, even in a subset of the T cells, using the gold standard approach of "pattern recognition." In addition to the pan-T-cell aberrancies, studies suggest that a cutoff value of 30% CD4+, CD26-and a phenotype of CD4+, CD26-, CD27+ may be useful markers in identifying the neoplastic lymphocytes in SS. [64] [65] [66] [67] [68] [69] Detection of T-cell clonality by PCR analysis of Southern blot may be of value if the presence of Sézary cells can be supported by morphology and flow cytometric immunophenotyping.
Conclusions
MF is usually a chronic indolent disease, and most patients have a long history of patch or plaque lesions on non-sun-exposed skin, such as the buttocks. The diagnosis should not be made without knowledge of the clinical findings. The cytologic appearance of the cerebriform lymphocytes and their location in the epidermis are critical diagnostic features. Folliculotropic cases are often associated with mucinosis and may have minimal epidermal involvement. Most cases are derived from CD4+ memory T cells, but phenotypic aberrancies and CD8+ cases occur. CD30+ large cells may be present and increase with LCT. Patients with a history of MF and CD30+ LCT should not be misclassified as having cutaneous ALCL. Although rare, MF and primary cutaneous CD30+ LPDs, such as LyP, may be seen in the same patient. Loss of CD7 is common but lacks specificity because it occurs in benign skin infiltrates, and loss of CD5 or CD2 may be more significant. Similarly, the finding of clonal T-cell gene rearrangements should be interpreted with caution because they are known to occur in benign skin infiltrates. Repeated biopsies showing the same clonal population may be helpful. In doubtful cases with early lesions, it is preferable to defer a definite diagnosis of malignancy to follow-up biopsies. Differential diagnosis includes both benign and neoplastic conditions, such as adult T-cell leukemia/lymphoma, which can mimic MF when they involve the skin. Although patients with MF may have erythroderma and circulating neoplastic cells, they should not be confused with cases of SS, which requires erythroderma, lymphadenopathy, and a significant population of neoplastic circulating Sézary cells for the diagnosis. with a history of chronic skin lesions and generalized erythroderma for 3 to 4 years who presented with progressive rash and fevers. The patient had diffuse erythema and numerous plaques, nodules, and tumors, of which many had erosion, covering more than 90% of the body surface. There were multiple large tumor nodules on his scalp and forehead. Computed tomography examination revealed lymphadenopathy without visceral involvement. The WBC count was 29,000/ mL, but no differentials were available. A biopsy specimen of 1 large tumor nodule demonstrated an atypical lymphoid infiltrate involving the full thickness of skin with epidermotropism, including 1 Pautrier microabscess. The atypical lymphocytes were predominantly small to intermediate sized with cerebriform nuclei. A blood smear showed scattered atypical lymphocytes with irregular nuclei, and abnormal CD4+ T cells were detected by flow cytometry. Testing for human T-lymphotrophic virus types 1 and 2 was negative. The panel performed a PD-1 immunohistochemical stain on the skin biopsy specimen, and the result was negative. The panel diagnosis was tumor stage MF based on the clinical presentation of chronic skin lesions with plaques and progressive tumor nodules, skin biopsy specimen findings with characteristic histologic features of tumor stage MF, lymphadenopathy, PD-1 negativity, and the lab results. 
